ucsf logo

Christina Mangurian, MD, MS

Perinatal Mental Health • Perinatal Psychiatry
Obstetrics & Gynecology Mission Bay – 4th St.
415-353-3400
ucsf logo

Christina Mangurian, MD, MS

Perinatal Mental Health • Perinatal Psychiatry
Obstetrics & Gynecology Mission Bay – 4th St.
415-353-3400

On this page

About me

Dr. Christina Mangurian is a psychiatrist who cares for pregnant women and women who have recently given birth. She serves as vice chair for diversity and health equity at the UCSF Weill Institute for Neurosciences.

Mangurian's research focuses on reducing health care disparities among racially diverse populations with severe mental illness. She is also interested in studying ways to support the advancement of women and minorities within medicine.

Mangurian earned her medical degree from UCSF. She completed a residency in psychiatry at Columbia University Irving Medical Center and a fellowship in public psychiatry at the New York State Psychiatric Institute, part of the Columbia Department of Psychiatry. She completed a master of advanced study degree in clinical research at UCSF.

Mangurian received the UCSF Chancellor Award for Advancement of Women in 2017 and the UCSF Distinction in Faculty Mentoring Award in 2018. She has been published extensively, including in the New England Journal of Medicine, Journal of the American Medical Association and American Journal of Psychiatry.

Education & training

Board certification

  • Psychiatry, American Board of Psychiatry and Neurology

Residency

  • Psychiatry, New York Presbyterian /Columbia GME

Degree

  • MD, UCSF School of Medicine

My expertise

Locations

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.